Related Experiment Video
Updated: Jul 9, 2025

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
Approach to vaccinating the pediatric solid organ transplant candidate and recipient
Carol M Kao1, Marian G Michaels2
1Department of Pediatrics, Washington University in St. Louis, St. Louis, MO, United States.
Insights
Solid organ transplant (SOT) candidates and recipients face high risks from infections. This review offers expert guidance on vaccinating pediatric SOT patients, addressing knowledge gaps for improved outcomes.
Area of Science:
- Immunology
- Transplant Medicine
- Vaccinology
Background:
- Solid organ transplantation (SOT) candidates and recipients have increased vulnerability to vaccine-preventable infections.
- Pediatric SOT recipients face unique challenges due to incomplete primary immunization and lack of natural immunity.
- Existing guidelines for SOT vaccination have limitations, especially concerning safety and efficacy data for live-vaccines in pediatric populations.
Purpose of the Study:
- To provide a practical, expert-opinion review on vaccinating SOT candidates and recipients.
- To supplement current vaccination guidelines with actionable insights.
- To highlight pediatric-specific knowledge gaps and future research directions in SOT vaccination.
Main Methods:
- This review synthesizes current literature and expert consensus.
- It focuses on practical considerations for timing and vaccine selection post-transplant.
- The review addresses challenges related to immunosuppression and exposure risks.
Main Results:
- Vaccination is crucial for preventing morbidity and mortality in SOT patients.
- Individualized vaccination strategies are necessary, considering patient-specific factors.
- Live-vaccine use in pediatric SOT recipients requires careful consideration due to limited data.
Conclusions:
- Optimizing vaccination schedules is essential for protecting SOT candidates and recipients.
- Further research is needed to address safety and efficacy of vaccines, particularly live-vaccines, in pediatric SOT recipients.
- Expert opinion and tailored approaches can improve vaccine coverage and outcomes in this vulnerable population.
Abstract:
Solid organ transplantation (SOT) candidates and recipients are at increased risk for morbidity and mortality from vaccine-preventable infections. Children are at particular risk given that they may not have completed their primary immunization series at time of transplant or have acquired natural immunity to pathogens from community exposures. Multiple society guidelines exist for vaccination of SOT candidate and recipients, although challenges remain given limited safety and efficacy data available for pediatric SOT recipients, particularly for live-vaccines. After transplant, individual patient nuances regarding exposure risks and net state of immunosuppression will impact timing of immunizations. The purpose of this review is to provide readers with a concise, practical, expert-opinion on the approach to vaccinating the SOT candidate and recipient and to supplement existing guidelines. In addition, pediatric-specific knowledge gaps in the field and future research priorities will be highlighted.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Cell-mediated Immune Responses

